BioCryst is a late-stage biotech company that is committed to delivering extraordinary medicines that help patients live ordinary lives.
At BioCryst, we are passionate about advancing novel therapeutics for patients with rare and serious diseases.
BioCryst has its headquarters in Durham, North Carolina and its Discovery Center of Excellence in Birmingham, Alabama. With expertise in drug discovery, clinical development, and regulatory affairs, we are advancing clinical programs and generating new compounds from our own discovery engine.
O/S Believed to be
176,000,000 per company website June 6, 2020
A/S 450M per filing May 2020